Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Infertility in Females01:28

Infertility in Females

291
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
291
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

347
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
347
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

464
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
464
Ovaries01:26

Ovaries

798
The ovaries are roughly the size of almonds and measure approximately 2 to 3 centimeters in length. These paired structures are situated within the pelvic region and are anchored by the mesovarium—a peritoneal extension that also connects them to the wider structure of the broad ligament. The support system extends to the suspensory ligament, housing blood and lymphatic vessels. In addition, the ovarian ligament tethers the ovaries to the uterus.
On the ovarian surface, a layer of...
798
Ovarian Cycle01:27

Ovarian Cycle

1.1K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.1K
Oogenesis02:07

Oogenesis

63.6K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Fattening mother's milk with oxytocin.

Science signaling·2026
Same author

In Science Journals.

Science (New York, N.Y.)·2026
Same author

In Science Journals.

Science (New York, N.Y.)·2026
Same author

In Science Journals.

Science (New York, N.Y.)·2026
Same author

RXRα marks the spot for Crohn's disease.

Science signaling·2026
Same author

In Science Journals.

Science (New York, N.Y.)·2026

相关实验视频

Updated: Jun 23, 2025

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome
04:49

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome

Published on: July 5, 2024

992

对于PCOS来说是一种肠道打击.

Wei Wong1

  • 1Science Signaling, AAAS, Washington, DC 20005, USA.

Science signaling
|June 18, 2024
PubMed
概括

一种肠道细菌代谢物抑制了类似葡萄糖-1 (GLP-1) 的释放,这是代谢调节中的关键激素. 这种抑制被确定为女性多囊性卵巢综合征 (PCOS) 的新病因.

科学领域:

  • 内分泌学 在内分泌学.
  • 微生物组研究 微生物组研究
  • 生殖医学 生殖医学

背景情况:

  • 多囊卵巢综合征 (PCOS) 是一种复杂的内分泌疾病,影响生殖和代谢健康.
  • 肠道微生物组在PCOS病原体中的作用越来越被认可,但尚未完全阐明.
  • 类似葡萄糖类-1 (GLP-1) 是一种关键的隐形激素,参与葡萄糖稳定和食欲调节,可能对PCOS产生影响.

研究的目的:

  • 调查肠道微生物群代谢物和PCOS发展之间的因果关系.
  • 为了确定影响GLP-1分泌的特定微生物代谢物.
  • 阐明改变GLP-1信号传导对PCOS病理生理学的机制.

主要方法:

  • 在PCOS患者和对照组中分析便微生物群组成和代谢物概况.
  • 使用肠道细胞系进行体外研究,以评估已识别的代谢物对GLP-1释放的影响.
  • 使用动物模型的体内研究证实了特定代谢物和GLP-1抑制在PCOS诱导中的作用.

主要成果:

  • 发现一种特定的肠道微生物群衍生代谢物可显著抑制GLP-1的释放.
  • 在实验模型中,降低的GLP-1水平与关键的PCOS表型相关,包括过高雄激素和无排卵.

更多相关视频

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
09:44

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

2.9K
A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
08:20

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

11.2K

相关实验视频

Last Updated: Jun 23, 2025

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome
04:49

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome

Published on: July 5, 2024

992
Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
09:44

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

2.9K
A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
08:20

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

11.2K
  • 已识别的代谢物的耗尽或恢复GLP-1信号改善了PCOS症状.
  • 结论:

    • 肠道微生物群的代谢物可以直接抑制GLP-1分泌,这代表了PCOS发展的新机制.
    • 准肠道微生物群或调节GLP-1信号可能为PCOS提供新的治疗策略.
    • 这项研究强调了肠道微生物群和内分泌功能在生殖健康障碍中的复杂相互作用.